Login / Signup
Timothy Michael Skerry
(Timothy M Skerry)
ORCID
Publication Activity (10 Years)
Years Active: 2021-2022
Publications (10 Years): 3
Top Topics
Community Dwelling
Blood Pressure
Small Molecule
Blood Glucose
Top Venues
Expert opinion on drug discovery
Journal of medicinal chemistry
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Ameera B A Jailani
,
Kamilla J A Bigos
,
Paris Avgoustou
,
Joseph L Egan
,
Robert A Hathway
,
Timothy Michael Skerry
,
Gareth O Richards
Targeting the adrenomedullin-2 receptor for the discovery and development of novel anti-cancer agents.
Expert opinion on drug discovery
17 (8) (2022)
Hasmik Jasmine Samvelyan
,
John Cummings Mathers
,
Timothy Michael Skerry
Feeding intervention potentiates the effect of mechanical loading to induce new bone formation in mice.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
35 (10) (2021)
Jean-Olivier Zirimwabagabo
,
Ameera B A Jailani
,
Paris Avgoustou
,
Matthew J Tozer
,
Karl R Gibson
,
Paul A Glossop
,
James E J Mills
,
Roderick A Porter
,
Paul Blaney
,
Ning Wang
,
Timothy Michael Skerry
,
Gareth O Richards
,
Joseph P A Harrity
Discovery of a First-In-Class Small Molecule Antagonist against the Adrenomedullin-2 Receptor: Structure-Activity Relationships and Optimization.
Journal of medicinal chemistry
64 (6) (2021)